Patents by Inventor Kevin Allen

Kevin Allen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11667889
    Abstract: This disclosure relates to compositions comprising human preprimitive streak cells and/or human mesendoderm cells as well as methods for their production. Additionally, disclosed herein are methods of identifying factors useful in the further differentiation of preprimitive streak and mesendoderm cell types.
    Type: Grant
    Filed: December 17, 2019
    Date of Patent: June 6, 2023
    Assignee: ViaCyte, Inc.
    Inventors: Kevin Allen D'Amour, Alan D. Agulnick, Susan Eliazer, Evert Kroon, Emmanuel E. Baetge
  • Publication number: 20230165908
    Abstract: A human immature endocrine cell population and methods for making an immature endocrine cell population are provided. Specifically, immature beta cells and methods for production of immature beta cells are described. Immature beta cells co-express INS and NKX6.1 and are uni-potent and thereby develop into mature beta cells when implanted in vivo. The mature beta cells in vivo are capable of producing insulin in response to glucose stimulation.
    Type: Application
    Filed: August 24, 2022
    Publication date: June 1, 2023
    Applicant: ViaCyte, Inc.
    Inventors: Alan D. Agulnick, Kevin Allen D’Amour
  • Patent number: 11634434
    Abstract: Bifunctional molecules having first and second alpha-synuclein binding agents coupled by a linker are disclosed. The bifunctional molecules have potential utility in the diagnosis, treatment and/or prophylaxis of disorders in which alpha-synuclein is implicated, including Parkinson's disease. Methods of making and using the bifunctional molecules are disclosed.
    Type: Grant
    Filed: September 8, 2017
    Date of Patent: April 25, 2023
    Assignee: University of Saskatchewan
    Inventors: Joseph Kakish, Edward Krol, Jeremy Lee, Kevin Allen
  • Patent number: 11623023
    Abstract: Disclosed are devices and methods for transplanting cells, such as pancreatic endoderm cells, into a host. The devices include a non-woven fabric external to a cell-excluding membrane, and the non-woven fabric and/or cell-excluding membrane can be perforated. Treatment of the host with immunosuppressive reagents, required to inhibit allograft rejection due to perforations in the cell delivery device, does not compromise maturation or function of transplanted pancreatic endoderm cells.
    Type: Grant
    Filed: November 10, 2016
    Date of Patent: April 11, 2023
    Assignee: ViaCyte, Inc.
    Inventors: Kevin Allen D'Amour, Evert Kroon, Michael Scott, Laura Martinson, Craig McGreevy
  • Publication number: 20230040286
    Abstract: Disclosed herein are cell cultures comprising dorsal and/or ventral PDX1-positive foregut endoderm cells and methods of producing the same. Also disclosed herein are cell populations comprising substantially purified dorsal and/or ventral PDX1-positive foregut endoderm cells as well as methods for enriching, isolating and purifying dorsal and/or ventral PDX1-positive foregut endoderm cells from other cell types. Methods of identifying differentiation factors capable of promoting the differentiation of dorsal and/or ventral PDX1-positive foregut endoderm cells, are also disclosed.
    Type: Application
    Filed: July 25, 2022
    Publication date: February 9, 2023
    Applicant: ViaCyte, Inc.
    Inventors: Kevin Allen D'Amour, Alan D. Agulnick, Susan Eliazer, Emmanuel E. Baetge
  • Patent number: 11446335
    Abstract: A human immature endocrine cell population and methods for making an immature endocrine cell population are provided. Specifically, immature beta cells and methods for production of immature beta cells are described. Immature beta cells co-express INS and NKX6.1 and are uni-potent and thereby develop into mature beta cells when implanted in vivo. The mature beta cells in vivo are capable of producing insulin in response to glucose stimulation.
    Type: Grant
    Filed: June 25, 2019
    Date of Patent: September 20, 2022
    Assignee: ViaCyte, Inc.
    Inventors: Alan D. Agulnick, Kevin Allen D'Amour
  • Patent number: 11427805
    Abstract: Disclosed herein are cell cultures comprising dorsal and/or ventral PDX1-positive foregut endoderm cells and methods of producing the same. Also disclosed herein are cell populations comprising substantially purified dorsal and/or ventral PDX1-positive foregut endoderm cells as well as methods for enriching, isolating and purifying dorsal and/or ventral PDX1-positive foregut endoderm cells from other cell types. Methods of identifying differentiation factors capable of promoting the differentiation of dorsal and/or ventral PDX1-positive foregut endoderm cells, are also disclosed.
    Type: Grant
    Filed: November 26, 2018
    Date of Patent: August 30, 2022
    Assignee: ViaCyte, Inc.
    Inventors: Kevin Allen D'Amour, Alan D. Agulnick, Susan Eliazer, Emmanuel E. Baetge
  • Patent number: 11326160
    Abstract: This disclosure provides, among other things, a method for making a cDNA library. In some embodiments the method may comprise reverse transcribing mRNA to produce DNA:mRNA hybrids, treating the DNA:mRNA hybrids with RNAseH to produce mRNA fragments, and reverse transcribing the mRNA fragments.
    Type: Grant
    Filed: June 3, 2020
    Date of Patent: May 10, 2022
    Assignee: BIOO SCIENTIFIC CORPORATION
    Inventors: Kevin Allen, Adam Morris
  • Patent number: 11270252
    Abstract: In one embodiment, a system and method of predicting sale transaction conversion rate of an item operates through a search of information in response to a query over a network. The item can be included in a category of items. Information for other relevant items of the category is available through network query and historical data, among others. Respective information for the other items of the category is available to the method.
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: March 8, 2022
    Assignee: VAST.COM, INC.
    Inventors: Komal Singh Sethi, Milos Milinko Tatarevic, Aleksandar Milutin Bradic, Kevin Allen Laws
  • Publication number: 20220056405
    Abstract: Disclosed herein are cell cultures comprising definitive endoderm cells and methods of producing the same. Also disclosed herein are cell populations comprising substantially purified definitive endoderm cells as well as methods for enriching, isolating and purifying definitive endoderm cells from other cell types.
    Type: Application
    Filed: November 5, 2021
    Publication date: February 24, 2022
    Applicant: ViaCyte, Inc.
    Inventors: Kevin Allen D'Amour, Alan D. Agulnick, Emmanuel E. Baetge
  • Patent number: 11136007
    Abstract: The present invention is an apparatus for tire inflation designed to allow users to properly inflate, maintain, and monitor the condition of vehicle tires. The tire inflation device of present invention is comprising of: a carrying case having a housing, a lid attached to the housing using a hinge, a plurality of locking latches to lock the lid over the housing and a handle configured over the lid to allow easy transport of the tire inflating device. The tire inflation device further comprises, a control head assembly to control the working of the device, an air compressor coupled with the control head assembly to provide compressed air for inflation of tires, a hose assembly to connect the device with the vehicle tires and a plurality of power adapters to connect the device with the power source.
    Type: Grant
    Filed: April 24, 2019
    Date of Patent: October 5, 2021
    Inventor: Kevin Allen Hibbard
  • Patent number: 11104941
    Abstract: This disclosure provides, among other things, a 5? adapter of the formula 3?*—X—(5?5?)—Y—3?, where: 3?* is a blocked 3? end, X is a synthetic sequence, (5?5?) is an internal 5?-5? linkage, Y is an adapter sequence, and 3? is a hydroxylated 3? end. In use, sequence X hybridizes to sequence X? in a population of RNA molecules of formula R—X?, which increases the efficiency of ligation of the 5? adapter to the nucleic acid molecules.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: August 31, 2021
    Assignee: BIOO SCIENTIFIC CORPORATION
    Inventors: Kevin Allen, Suk Ho Eun
  • Patent number: 11022996
    Abstract: One example aspect of the present disclosure relates to a method. The method can include receiving, by one or more computing devices, an input related to power consumption. The method can include filtering, by the one or more computing devices, the received input. The method can include classifying, by the one or more computing devices, the filtered input into one zone of a plurality of zones. The method can include determining, by the one or more computing devices, a setting associated with the classified zone. The setting can determine power production during an idle setting. The method can include causing, by the one or more computing devices, an adjustment to the determined setting at a rate determined by a rate limit.
    Type: Grant
    Filed: July 2, 2018
    Date of Patent: June 1, 2021
    Assignee: General Electric Company
    Inventors: Robert Schroer, Kevin Allen Davis
  • Patent number: 10954542
    Abstract: This disclosure provides, among other things, a method for making a cDNA library. In some embodiments the method may comprise adding a polyA tail to the longer RNA fragments but not the shorter RNA fragments in a sample by incubating the population of RNA fragments with a polyA polymerase, wherein the reaction conditions used preferentially tail only the longer fragments but not the shorter fragments.
    Type: Grant
    Filed: May 20, 2020
    Date of Patent: March 23, 2021
    Assignee: BIOO SCIENTIFIC CORPORATION
    Inventor: Kevin Allen
  • Publication number: 20200291393
    Abstract: This disclosure provides, among other things, a method for making a cDNA library. In some embodiments the method may comprise reverse transcribing mRNA to produce DNA:mRNA hybrids, treating the DNA:mRNA hybrids with RNAseH to produce mRNA fragments, and reverse transcribing the mRNA fragments.
    Type: Application
    Filed: June 3, 2020
    Publication date: September 17, 2020
    Inventors: Kevin Allen, Adam Morris
  • Publication number: 20200283813
    Abstract: This disclosure provides, among other things, a method for making a cDNA library. In some embodiments the method may comprise adding a polyA tail to the longer RNA fragments but not the shorter RNA fragments in a sample by incubating the population of RNA fragments with a polyA polymerase, wherein the reaction conditions used preferentially tail only the longer fragments but not the shorter fragments.
    Type: Application
    Filed: May 20, 2020
    Publication date: September 10, 2020
    Inventor: Kevin Allen
  • Patent number: 10769234
    Abstract: Examples herein involve a document object model (DOM) transaction crawler. Examples herein involve identifying an event in a first state of a document object model. The event is executed to cause a state change from the first state of the document object model to a second state of the document object model. Furthermore, the state change is stored in a transaction log to store the difference between the first state of the document object model and the second state of the document object model.
    Type: Grant
    Filed: August 18, 2017
    Date of Patent: September 8, 2020
    Assignee: MICRO FOCUS LLC
    Inventors: Thomas Christopher Swedlund, Kevin Allen Williams, Brian Charles King
  • Publication number: 20200248137
    Abstract: This disclosure relates to compositions comprising human preprimitive streak cells and/or human mesendoderm cells as well as methods for their production. Additionally, disclosed herein are methods of identifying factors useful in the further differentiation of preprimitive streak and mesendoderm cell types.
    Type: Application
    Filed: December 17, 2019
    Publication date: August 6, 2020
    Applicant: ViaCyte, Inc.
    Inventors: Kevin Allen D'Amour, Alan D. Agulnick, Susan Eliazer, Evert Kroon, Emmanuel E. Baetge
  • Patent number: 10728328
    Abstract: An Ethernet SAN system includes an initiator device and a target device coupled together by an Ethernet fabric that includes a plurality of Ethernet switch devices. The Ethernet switch devices exchange L2 FIP domain exchange multicast frames that include domain information associated with each of the Ethernet switch devices. That domain information is then used to exchange L2 FIP path exchange multicast frames that include path information associated with each of the Ethernet switch devices. That path information is then used to calculate path costs associated with at least some of the Ethernet switch devices. Those path costs are then used to exchange L2 FIP device exchange unicast frames that include device information associated with the initiator device and the target device. The Ethernet switch devices then transmit data between the initiator device and the target device based on the device information and the path costs.
    Type: Grant
    Filed: April 19, 2016
    Date of Patent: July 28, 2020
    Assignee: Dell Products L.P.
    Inventors: Kevin Allen Hughes, Joseph LaSalle White, Jason Garth Pearce
  • Patent number: 10711271
    Abstract: This disclosure provides, among other things, a method for making a cDNA library. In some embodiments the method may comprise reverse transcribing mRNA to produce DNA:mRNA hybrids, treating the DNA:mRNA hybrids with RNAseH to produce mRNA fragments, and reverse transcribing the mRNA fragments.
    Type: Grant
    Filed: November 20, 2017
    Date of Patent: July 14, 2020
    Assignee: BIOO SCIENTIFIC CORPORATION
    Inventors: Kevin Allen, Adam Morris